Tamiflu Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial
An amendment to this paper has been published and can be accessed via the original article. (Source: Trials)
Source: Trials - August 21, 2020 Category: Research Source Type: clinical trials

IMU-838 and Oseltamivir in the Treatment of COVID-19
Condition:   Covid 19 Interventions:   Drug: IMU-838;   Drug: Oseltamivir Sponsors:   University Hospitals Coventry and Warwickshire NHS Trust;   Immunic AG;   University of Warwick;   MODEPHARMA Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2020 Category: Research Source Type: clinical trials